SCHEMBL9913880

SCHEMBL9913880

CC(C)(C)OC(=O)N[C@H]1C[C@H](Oc2cc(F)cc(F)c2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.44
BTK Q06187 1/20 0.42
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PARP1 P09874 2/20 0.41
KDM1A O60341 2/20 0.40
MAOB P27338 1/20 0.40
PIK3CD O00329 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
GAA P10253 1/20 0.38
EPAS1 Q99814 1/20 0.38
PARP2 Q9UGN5 1/20 0.37
CTSK P43235 2/20 0.36
KDM4D Q6B0I6 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36
JAK2 O60674 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29874277 1.00 EPHX2 (0.44) EPHX2BTKKMT2AL3MBTL1PARP1
SCHEMBL24975362 0.88 BTK (0.41) EPHX2BTKKMT2AL3MBTL1PARP1
SCHEMBL29279741 0.88 BTK (0.41) EPHX2BTKKMT2AL3MBTL1PARP1
SCHEMBL29991301 0.87 SLC6A2 (0.47) EPHX2BTKKMT2AL3MBTL1KDM1A
SCHEMBL29991836 0.87 SLC6A2 (0.47) EPHX2BTKKMT2AL3MBTL1KDM1A
SCHEMBL29874623 0.87 PIK3CD (0.41) EPHX2BTKKMT2AL3MBTL1PARP1
SCHEMBL23951710 0.86 KDM1A (0.47) EPHX2BTKKMT2AL3MBTL1KDM1A
SCHEMBL29874984 0.86 BTK (0.43) EPHX2BTKKMT2AL3MBTL1KDM1A
SCHEMBL29874307 0.86 BTK (0.39) EPHX2BTKKMT2AL3MBTL1PARP1
SCHEMBL29874542 0.85 FFAR4 (0.39) EPHX2BTKKMT2AL3MBTL1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012072512-A1 N-CYCLOBUTYL-IMIDAZOPYRIDINE OR -PYRAZOLOPYRIDINE CARBOXAMIDES AS TRPV1 ANTAGONISTS GLAXO GROUP LIMITED (GB) 2012-06-07 WO disclosed